Nelfinavir and lenalidomide/dexamethasone in patients with lenalidomide-refractory multiple myeloma. A phase I/II Trial (SAKK 39/10)
Hitz, F, Kraus, M, Pabst, T, Hess, D, Besse, L, Silzle, T, Novak, U, Seipel, K, Rondeau, S, Stüdeli, S, Vilei, S Berardi, Samaras, P, Mey, U, Driessen, C
Published in Blood cancer journal (New York) (27.08.2019)
Published in Blood cancer journal (New York) (27.08.2019)
Get full text
Journal Article